glp 1 immune system What is GLP-1 and Its Receptor Agonists? Beyond metabolic benefits: The underexplored

Clinical studies have shown that semaglutide can lead to significant weight loss when combined with a healthy lifestyle

The FDA has issued warnings about unapproved GLP-1 drugs circulating online - counterfeit, compounded, or mislabeled as research use only. When access to legitimate GLP-1 clinical trials is limited - by geography, logistics, or site capacity - progress slows

/PRNewswire/ -- Supergut, the leader in gut-health innovation, is shaking up summer wellness with the launch of three refreshing new flavors of its...

In most major obesity trials, GLP-1 therapy was: Escalated to high or maximum tolerated doses Stopped abruptly, not down-titrated Followed by little or no continuation of structured lifestyle support In the STEP-1 extension trial (semaglutide 2.4 mg), participants who discontinued therapy regained approximately two-thirds of their prior weight loss over the following year

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

By May 2025, GLP-1s accounted for 52% of all diabetes prescription volume, up from just 18% in 2020